111 related articles for article (PubMed ID: 3873754)
1. [Hepatitis A antibodies in young hemophiliacs].
Schiller WG; Doroshenko NW; Stakhanova VM; Remde W
Z Gesamte Inn Med; 1985 Mar; 40(6):183-5. PubMed ID: 3873754
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatitis A in Dutch hemophilia patients.
Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; van den Berg HM; Roosendaal G; Lelie PN
Thromb Haemost; 1995 Aug; 74(2):616-8. PubMed ID: 8584994
[TBL] [Abstract][Full Text] [Related]
3. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
Mosley JW
Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland].
Perret BA; Senn M; Affentranger P; Poorbeik M; Burckhardt JJ; Morell A
Schweiz Med Wochenschr; 1993 Jan; 123(3):79-81. PubMed ID: 7678942
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against Australia-antigen in haemophilia.
Nordenfelt E; Nilsson IM
Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
[No Abstract] [Full Text] [Related]
6. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center.
Brackmann HH; Oldenburg J; Eis-Hübinger AM; Gerritzen A; Hammerstein U; Hanfland P
Vox Sang; 1994; 67 Suppl 1():3-7; discussion 8. PubMed ID: 8091733
[TBL] [Abstract][Full Text] [Related]
7. [NANB-hepatitis associated marker ("C") in hemophilia].
Renger FG; Wendtland H; Schiller WG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):887-93. PubMed ID: 6200401
[TBL] [Abstract][Full Text] [Related]
8. Infection of hepatitis A virus in Japanese haemophiliacs.
Hayashi K; Fukuda Y; Nakano I; Katano Y; Nagano K; Yokozaki S; Hayakawa T; Toyoda H; Takamatsu J
J Infect; 2001 Jan; 42(1):57-60. PubMed ID: 11243755
[TBL] [Abstract][Full Text] [Related]
9. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of anti-HAV antibodies in selected groups of children].
Ryszkowska A; Gładysz A; Inglot M; Molin I
Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of hepatitis A in hemophiliacs].
Molina R; Lorenzo JI; Gómez MD; Sarrión A; Haya S; Querol F; Aznar JA
Sangre (Barc); 1996 Oct; 41(5):363-5. PubMed ID: 9026922
[TBL] [Abstract][Full Text] [Related]
12. [Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis].
Angarano G; Coppola S; Frappampina V; Monno L; Santantonio T
Boll Ist Sieroter Milan; 1982; 61(5):383-9. PubMed ID: 6100166
[TBL] [Abstract][Full Text] [Related]
13. Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity?
Peerlinck K; Goubau P; Coppens G; Desmyter J; Vermylen J
Vox Sang; 1994; 67 Suppl 1():14-6; discussion 17. PubMed ID: 8091728
[TBL] [Abstract][Full Text] [Related]
14. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand.
Poovorawan Y; Vimolkej T; Chongsrisawat V; Theamboonlers A; Chumdermpadetsuk S
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):154-7. PubMed ID: 9322299
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
[TBL] [Abstract][Full Text] [Related]
16. [Seroepidemiologic study of the prevalence of anti-HAV antibodies in children in Rome].
Catania S; Ajassa C; Tzantzoglou S; Bellagamba R; Berardelli G; Catania N
Riv Eur Sci Med Farmacol; 1996; 18(1):7-9. PubMed ID: 8766776
[TBL] [Abstract][Full Text] [Related]
17. [Immunity against hepatitis A in younger age groups and the basis for an immunization program].
Puntarić D; Vodopija I; Baklaić Z; Ljubicić M
Lijec Vjesn; 1995; 117(7-8):167-72. PubMed ID: 8656973
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.
Fock KM; Tay HH; Phua KB; Guan R; Chia SC; Chong R; Chee AE; Chew CN
Singapore Med J; 1995 Feb; 36(1):26-7. PubMed ID: 7570129
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
20. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.
Dal-Ré R; García-Corbeira P; García-de-Lomas J
J Med Virol; 2000 Apr; 60(4):363-6. PubMed ID: 10686017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
